Question 1

What is the catalog number for P19INK4d (cdk4, cdk6 Inhibitor, Mitotic Inhibitor/Suppressor Protein, Cyclin-dependent Kinase Inhibitor) (AP) discontinued?

Accepted Answer

The catalog number for P19INK4d (cdk4, cdk6 Inhibitor, Mitotic Inhibitor/Suppressor Protein, Cyclin-dependent Kinase Inhibitor) (AP) discontinued is P1000-38-AP.

Question 2

What sizes are available for P19INK4d (cdk4, cdk6 Inhibitor, Mitotic Inhibitor/Suppressor Protein, Cyclin-dependent Kinase Inhibitor) (AP) discontinued?

Accepted Answer

P19INK4d (cdk4, cdk6 Inhibitor, Mitotic Inhibitor/Suppressor Protein, Cyclin-dependent Kinase Inhibitor) (AP) discontinued is available in the following size(s): 100 µL.

Question 3

Is P19INK4d (cdk4, cdk6 Inhibitor, Mitotic Inhibitor/Suppressor Protein, Cyclin-dependent Kinase Inhibitor) (AP) discontinued in stock?

Accepted Answer

P19INK4d (cdk4, cdk6 Inhibitor, Mitotic Inhibitor/Suppressor Protein, Cyclin-dependent Kinase Inhibitor) (AP) discontinued

Selected Variant

P1000-38-AP

Size: 100 µL

Product Specifications

Clonality

Mab

Question 4

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Question 5

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.